Interleukin-10 levels and the risk of thromboembolism according to COMPASS-Cancer associated thrombosis score in breast cancer patients prior to undergoing doxorubicin-based chemotherapy-Reference-Cited by-同舟云学术

Interleukin-10 levels and the risk of thromboembolism according to COMPASS-Cancer associated thrombosis score in breast cancer patients prior to undergoing doxorubicin-based chemotherapy

Published:2022-08-09 Issue:1 Volume:34 Page:70-74
ISSN:0957-5235
Container-title:Blood Coagulation & Fibrinolysis
language:en
Short-container-title:

Author:

Pestana Rodrigo M.C.,Alves Michelle T.,de Oliveira Angélica N.,Oliveira Heloísa H.M.,Soares Cintia E.,Sabino Adriano de P.,Silva Luciana M.,Simões Ricardo,Gomes Karina B.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hematology,General Medicine

Reference15 articles.

1. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. Risk prediction for cancer-associated thrombosis in ambulatory patients with cancer: past, present and future;Moik;Thromb Res,2020

3. Frequency, risk factors, and impact on mortality of arterial thromboembolism in patients with cancer;Grilz;Haematologica,2018

4. Overview of risk assessment models for venous thromboembolism in ambulatory patients with cancer;Gerotziafas;Thromb Res,2020

5. Inflammation, TNFα and endothelial dysfunction link lenalidomide to venous thrombosis in chronic lymphocytic leukemia;Aue;Am J Hematol,2011

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Coagulation and fibrinolytic markers offer utility when distinguishing between benign and malignant gallbladder tumors: A cross-sectional study;Clinica Chimica Acta;2024-06

2. The value of COMPASS-CAT risk assessment model in predicting venous thromboembolism in hospitalized patients with breast cancer, lung cancer, colorectal cancer and ovarian cancer;2024-03-22

3. Novel Insights in Venous Thromboembolism Risk Assessment Methods in Ambulatory Cancer Patients: From the Guidelines to Clinical Practice;Cancers;2024-01-21

4. Microparticles and cardiotoxicity secondary to doxorubicin-based chemotherapy in breast cancer patients;International Journal of Cardiology;2024-01